1. Home
  2. AMRC vs ARDX Comparison

AMRC vs ARDX Comparison

Compare AMRC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameresco Inc.

AMRC

Ameresco Inc.

HOLD

Current Price

$31.31

Market Cap

1.4B

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.95

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRC
ARDX
Founded
2000
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
AMRC
ARDX
Price
$31.31
$6.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$37.88
$15.14
AVG Volume (30 Days)
442.4K
2.9M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$1,769,928,000.00
$2,607,000.00
Revenue This Year
$10.71
$37.75
Revenue Next Year
$9.07
$34.24
P/E Ratio
$59.71
N/A
Revenue Growth
28.76
N/A
52 Week Low
$11.48
$3.50
52 Week High
$44.93
$8.40

Technical Indicators

Market Signals
Indicator
AMRC
ARDX
Relative Strength Index (RSI) 69.52 70.26
Support Level $29.05 $6.83
Resistance Level $34.29 $8.05
Average True Range (ATR) 1.32 0.32
MACD 0.55 0.06
Stochastic Oscillator 97.17 89.92

Price Performance

Historical Comparison
AMRC
ARDX

About AMRC Ameresco Inc.

Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: